Moises Hernandez is Vice President of ProSciento’s Clinical Research Unit. He is an expert in the field of metabolic clinical research and one of the foremost experts in glucose clamp methodologies and digital wearable technologies for the conduct of clinical trials.
As a Vice President, Moises leads the company’s state-of-art, early phase clinical research unit (CRU) in Chula Vista, CA, and is responsible for overseeing principal investigators, site operations, pharmaceutical services, clinical study management, and ensuring compliance with regulatory requirements. With over 15 years of experience at the company, he has contributed to more than 300 clinical research studies for metabolic therapeutics and devices and has been a member of the company’s senior leadership team for more than eight years, helping to manage company initiatives at a corporate level. He received his Bachelor of Medicine degree from the Universidad Autónoma de Baja California.